Status:
UNKNOWN
Validation of the Respiratory Function of Pulmonary Transplants to Anticipate Unplanned Hospitalizations
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Aqsitania SAS
AGIR à Dom
Conditions:
Lung Transplant; Complications
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute cellular and/or humoral rejection and early graft infections after pulmonary transplant (\<2.5 years) are common and can lead to chronic dysfunction of the transplanted organ or Chronic Lung All...
Detailed Description
Acute cellular and/or humoral rejection and early graft infections after pulmonary transplant (\<2.5 years) are common and can lead to chronic dysfunction of the transplanted organ or Chronic Lung All...
Eligibility Criteria
Inclusion
- Adult male or female, pulmonary transplant for at least three months but less than 2.5 years in stable condition (absence of unplanned hospitalization, antibiotic treatment or modification of treatment during the month preceding inclusion).
- Having given informed consent in writing and affiliated to a social security scheme.
Exclusion
- Home network coverage insufficient for data transmission.
- Proven psychiatric pathology.
- Cognitive problem significantly limiting the understanding of different instructions or evaluations.
- People referred to Articles L1121-5 to L1121-8 of the Code of Public Health.
Key Trial Info
Start Date :
February 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03368365
Start Date
February 7 2018
End Date
March 1 2019
Last Update
March 15 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Grenoble University Hospital
La Tronche, Auvergne-Rhône-Alpes, France, 38700
2
Lyon University Hospital
Lyon, Rhônes-Alpes, France, 69002